Clinical Trial Update: Comparing Neoadjuvant Chemotherapy Combined With PD-1 Inhibitor Versus Neoadjuvant Chemotherapy in Locally Advanced Laryngeal and Hypopharyngeal Carcinoma [Phase 3]

View source ↗

Summary

A Phase 3 trial is evaluating neoadjuvant chemotherapy with a PD-1 inhibitor versus neoadjuvant chemotherapy alone for locally advanced laryngeal and hypopharyn…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypopharyngeal Carcinoma
• Laryngeal Carcinoma

Drugs mentioned

• PD-1 inhibitor

Snippet

Sponsor: Fudan University | Conditions: Laryngeal Carcinoma, Hypopharyngeal Carcinoma | Phase 3 | Status: NOT_YET_RECRUITING